Free Trial

Vontier (VNT) Competitors

Vontier logo
$38.14 -1.29 (-3.27%)
(As of 12/17/2024 ET)

VNT vs. TER, AVTR, RVTY, BIO.B, NVMI, ST, MIR, TRNS, CTKB, and LAB

Should you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Mirion Technologies (MIR), Transcat (TRNS), Cytek Biosciences (CTKB), and Standard BioTools (LAB). These companies are all part of the "measuring and control equipment" industry.

Vontier vs.

Teradyne (NASDAQ:TER) and Vontier (NYSE:VNT) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

In the previous week, Teradyne had 8 more articles in the media than Vontier. MarketBeat recorded 21 mentions for Teradyne and 13 mentions for Vontier. Teradyne's average media sentiment score of 1.09 beat Vontier's score of 0.78 indicating that Teradyne is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teradyne
11 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Vontier
5 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.8% of Teradyne shares are owned by institutional investors. Comparatively, 95.8% of Vontier shares are owned by institutional investors. 0.4% of Teradyne shares are owned by company insiders. Comparatively, 0.8% of Vontier shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Teradyne has higher earnings, but lower revenue than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teradyne$2.68B7.79$448.75M$3.1540.64
Vontier$2.99B1.92$376.90M$2.6114.61

Teradyne has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Vontier has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

Teradyne presently has a consensus price target of $147.25, suggesting a potential upside of 15.03%. Vontier has a consensus price target of $44.44, suggesting a potential upside of 16.53%. Given Vontier's higher probable upside, analysts clearly believe Vontier is more favorable than Teradyne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teradyne
0 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.69
Vontier
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67

Teradyne received 28 more outperform votes than Vontier when rated by MarketBeat users. However, 50.62% of users gave Vontier an outperform vote while only 44.23% of users gave Teradyne an outperform vote.

CompanyUnderperformOutperform
TeradyneOutperform Votes
69
44.23%
Underperform Votes
87
55.77%
VontierOutperform Votes
41
50.62%
Underperform Votes
40
49.38%

Teradyne has a net margin of 18.75% compared to Vontier's net margin of 13.54%. Vontier's return on equity of 45.48% beat Teradyne's return on equity.

Company Net Margins Return on Equity Return on Assets
Teradyne18.75% 18.56% 13.91%
Vontier 13.54%45.48%10.49%

Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.4%. Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays out 15.2% of its earnings in the form of a dividend. Vontier pays out 3.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Teradyne beats Vontier on 14 of the 20 factors compared between the two stocks.

Get Vontier News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VNT vs. The Competition

MetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE Exchange
Market Cap$5.73B$6.20B$6.96B$19.63B
Dividend Yield0.25%0.42%2.90%3.51%
P/E Ratio14.6135.6446.0943.82
Price / Sales1.925.11449.9117.46
Price / Cash10.5334.1629.7221.73
Price / Book6.589.745.755.46
Net Income$376.90M$234.75M$124.96M$987.18M
7 Day Performance-2.63%-2.93%2.35%-2.12%
1 Month Performance0.16%2.82%9.56%1.31%
1 Year Performance9.22%28.96%32.49%16.44%

Vontier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VNT
Vontier
3.3393 of 5 stars
$38.14
-3.3%
$44.44
+16.5%
+9.2%$5.73B$2.99B14.618,000
TER
Teradyne
4.9092 of 5 stars
$129.55
+5.1%
$147.25
+13.7%
+21.7%$21.10B$2.68B39.126,500Analyst Upgrade
AVTR
Avantor
4.9487 of 5 stars
$22.35
+0.1%
$27.69
+23.9%
-4.5%$15.21B$6.97B48.5414,500
RVTY
Revvity
3.9594 of 5 stars
$115.22
-0.6%
$132.47
+15.0%
+13.4%$14.02B$2.72B56.0111,500Positive News
BIO.B
Bio-Rad Laboratories
N/A$337.08
flat
N/A+11.1%$9.44B$2.67B-12.338,200
NVMI
Nova
3.2225 of 5 stars
$191.05
+1.4%
$227.80
+19.2%
+49.3%$5.55B$611.85M35.423,606Positive News
ST
Sensata Technologies
4.664 of 5 stars
$30.19
-0.6%
$41.00
+35.8%
-18.2%$4.52B$4.05B-56.2419,400
MIR
Mirion Technologies
2.534 of 5 stars
$18.74
+3.9%
$18.33
-2.2%
+79.4%$4.35B$836.90M-54.323,000Positive News
TRNS
Transcat
2.9645 of 5 stars
$110.15
+0.9%
$130.25
+18.2%
+7.7%$1.01B$270.61M54.911,104
CTKB
Cytek Biosciences
2.7217 of 5 stars
$6.43
+3.5%
$9.25
+43.9%
-29.2%$828.26M$201.21M-77.63500Positive News
LAB
Standard BioTools
3.2118 of 5 stars
$2.12
+11.0%
$2.88
+35.6%
+11.1%$789.19M$155.90M-2.99620

Related Companies and Tools


This page (NYSE:VNT) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners